Alkermes plc.

ALKS · Nasdaq · SIC 2834: Pharmaceutical Preparations
177
SEC Filings

Business Summary

PART I The following discussion contains forward-looking statements. Actual results may differ significantly from those expressed or implied in the forward-looking statements. See Cautionary Note Concerning Forward-Looking Statements on page 3 of this Annual Report. Factors that might cause future results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, those discussed in Item 1ARisk Factors and elsewhere in this Annual Repor...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionALKSdiscussed_in_filing Cybersecurity
topic_mentionALKSdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-252025-12-310001193125-26-068925EDGAR93K words
2025-02-122024-12-310000950170-25-019011EDGAR—
2024-02-212023-12-310000950170-24-017883EDGAR—
2023-02-162022-12-310001564590-23-002020EDGAR—
2022-02-162021-12-310001564590-22-005304EDGAR—
2021-02-112020-12-310001564590-21-005593EDGAR—
2020-02-132019-12-310001564590-20-004489EDGAR—
2019-02-152018-12-310001564590-19-003060EDGAR—
2018-02-162017-12-310001520262-18-000016EDGAR—
2017-02-172016-12-310001520262-17-000007EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-282025-09-300001193125-25-252524EDGAR29K words
2025-07-292025-06-300000950170-25-099409EDGAR—
2025-05-012025-03-310000950170-25-061817EDGAR—
2024-10-242024-09-300000950170-24-116872EDGAR—
2024-07-242024-06-300000950170-24-085873EDGAR—
2024-05-012024-03-310000950170-24-051397EDGAR—
2023-10-252023-09-300000950170-23-055178EDGAR—
2023-07-262023-06-300000950170-23-034725EDGAR—
2023-04-262023-03-310001564590-23-006240EDGAR—
2022-11-022022-09-300000950170-22-021003EDGAR—
2022-07-272022-06-300001564590-22-026586EDGAR—
2022-04-272022-03-310001564590-22-015890EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-250001193125-26-068927EDGAR2K words
2026-02-250001193125-26-068512EDGAR—
2026-02-120001193125-26-047682EDGAR—
2026-01-120001193125-26-009813EDGAR—
2026-01-060001193125-26-003453EDGAR—
2025-11-190001193125-25-286909EDGAR—
2025-11-120001193125-25-276161EDGAR—
2025-10-280001193125-25-252207EDGAR—
2025-10-220001193125-25-245852EDGAR—
2025-09-120001193125-25-202307EDGAR—

177 total filings indexed. 145 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001520262
TickerALKS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fe4a8d7cc52c82e80649973820cc62e7d6a6d142a6591e35299220e7e86a3e66
parent: f064848aa522d6d656fbf78aaf2fffe9a907733c74a65a6f95810a14448d1690
content hash: e4f41bed0c3f54ac87a04408b70c795fc6bf7cd56ecca7f4243b42986143eba8
signed: 2026-04-13T04:43:35.389Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf